By Julia Berends, Cord Kühnl, and Lucy Goodacre The New Researcher Network (NRN) was founded as a sub-committee of the Drug Delivery to the Lungs (DDL) conference in 2019 to actively foster interaction and collaboration among early-career OINDP researchers and to build a robust community of emerging scholars. The first NRN lunch and evening session took place at … [Read more...] about The DDL New Researcher Network Expands its Activities
Features
Q&A with Copley’s Clair Brooks on in vitro testing for LGWP MDI reformulation
Copley Application Specialist Clair Brooks discusses new EMA guidance on data requirements associated with the transition to low global warming potential (LGWP) propellants in metered dose inhalers and strategies for the successful application of in vitro testing within this context. How does the 2023 EMA Q&A clarify data requirements for the LGWP transition … [Read more...] about Q&A with Copley’s Clair Brooks on in vitro testing for LGWP MDI reformulation
DDL 2023 highlighted novel technologies
The 34th iteration of the Drug Delivery to the Lungs (DDL) Conference, DDL 2023, drew approximately 930 OINDP specialists to the Edinburgh International Conference Centre (EICC) December 6 - 8, with more than 100 additional attendees joining online. The conference also drew support from 115 sponsors, including almost 20 new companies exhibiting for the first time. … [Read more...] about DDL 2023 highlighted novel technologies
Previewing DDL 2023
The annual Drug Delivery to the Lungs meeting returns to the Edinburgh International Conference Centre (EICC) December 6-8. DDL 2022 attracted a total of more than 1,000 delegates in person and online, and DDL 2023 is also expected to draw a large crowd, says organizing committee member Michelle Dawson. For the first time, DDL will take over the entire EICC, providing … [Read more...] about Previewing DDL 2023
ISAM Congress 2023
The International Society for Aerosols in Medicine (ISAM) welcomed more than 260 attendees to its 2023 biannual congress August 26-30 in Saarbrücken, Germany, reports organizing committee member Claus-Michael Lehr of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). In addition to the scientific program, the meeting included 6 workshops, 21 … [Read more...] about ISAM Congress 2023
Q&A with Intertek’s Chris Vernall on in-vitro only BE and the new nasal bioequivalence guidances
Intertek Pharmaceutical Services Commercial Director Chris Vernall on how the new FDA nasal bioequivalence guidances support an in vitro only bioequivalence pathway and continue wider industry focus on evolving analytical and in silico tools for generic OINDP testing What is the main difference in in-vitro bioequivalence (IVBE) recommendations between the May 2023 … [Read more...] about Q&A with Intertek’s Chris Vernall on in-vitro only BE and the new nasal bioequivalence guidances
Aerosol School goes virtual for 2023
After pausing for several years due to the COVID-19 pandemic, the 2023 edition of Aerosol School will take place virtually. Students will have access to more than 200 hours of lectures from well-known experts on topics ranging from the basics of aerosol delivery devices to hot topics such as the delivery of macrophages and monoclonal antibodies via inhalation. … [Read more...] about Aerosol School goes virtual for 2023
RDD Europe 2023 highlighted sustainability, nasal drug delivery, and biologics
At RDD Europe 2023, which took place May 2-5 in Antibes, France, Richard Dalby noted in his opening remarks that approximately 420 inhaled and nasal drug delivery experts from 28 countries were attending the conference in person with another 20 or so delegates attending virtually. Noting that 2023 was the first in-person version of RDD Europe since 2019, he welcomed … [Read more...] about RDD Europe 2023 highlighted sustainability, nasal drug delivery, and biologics
In Memoriam: Charles G. Thiel
Charles G. Thiel, one of the most influential scientists working in respiratory drug delivery over the past 7 decades, passed away on March 10, 2023 at the age of 94. In 1956, Thiel and co-workers at Riker Laboratories developed the first pressurized metered dose inhaler for delivery of medication to the lungs. Following the 1970 acquisition of Riker by 3M (now … [Read more...] about In Memoriam: Charles G. Thiel
RDD Europe 2023 returns to Antibes
RDD Europe 2023, organized by RDD Online and Aptar Pharma, returns to Antibes, France, May 2-5 at the Palais des Congrès Antipolis. Richard Dalby of RDD Online says that conference center (previously called the Palais des Congrès Antibes) proved popular with attendees at RDD Europe 2015 and 2017, which took place at the same venue. Dalby expects that attendance will … [Read more...] about RDD Europe 2023 returns to Antibes